Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Prednisolone/adverse effects"'
Autor:
Martin T Christian, Nicholas JA Webb, Rebecca L Woolley, Nafsika Afentou, Samir Mehta, Emma Frew, Elizabeth A Brettell, Adam R Khan, David V Milford, Detlef Bockenhauer, Moin A Saleem, Angela S Hall, Ania Koziell, Heather Maxwell, Shivaram Hegde, Eric R Finlay, Rodney D Gilbert, Caroline Jones, Karl McKeever, Wendy Cook, Natalie Ives
Publikováno v:
Health Technology Assessment, Vol 26, Iss 3 (2022)
Christian, M T, Webb, N J, Woolley, R L, Afentou, N, Mehta, S, Frew, E, Brettell, E A, Khan, A R, Milford, D V, Bockenhauer, D, Saleem, M A, Hall, A S, Koziell, A, Maxwell, H, Hegde, S, Finlay, E R, Gilbert, R D, Jones, C, McKeever, K, Cook, W & Ives, N 2022, ' Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection : PREDNOS2 RCT ', Health Technology Assessment, vol. 26, no. 3, pp. i-93 . https://doi.org/10.3310/WTFC5658
Christian, M T, Webb, N J, Woolley, R L, Afentou, N, Mehta, S, Frew, E, Brettell, E A, Khan, A R, Milford, D V, Bockenhauer, D, Saleem, M A, Hall, A S, Koziell, A, Maxwell, H, Hegde, S, Finlay, E R, Gilbert, R D, Jones, C, McKeever, K, Cook, W & Ives, N 2022, ' Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection : PREDNOS2 RCT ', Health Technology Assessment, vol. 26, no. 3, pp. i-93 . https://doi.org/10.3310/WTFC5658
Background Most children with steroid-sensitive nephrotic syndrome have relapses that are triggered by upper respiratory tract infections. Four small trials, mostly in children already taking maintenance corticosteroid in countries of different upper
Autor:
Snijders, R.J.A.L.M., Stoelinga, A.E.C., Gevers, T.J.G., Pape, S., Biewenga, M., Verdonk, R.C., Jonge, H.J.M. de, Vrolijk, J.M., Bakker, S.F., Vanwolleghem, T., Boer, Y.S. de, Pronk, M.A.M.C.B., Beuers, U.H.W., Meer, A.J. van der, Gerven, N.M.F. van, Sijtsma, M.G.M., Verwer, B.J., Gisbertz, I.A.M., Bartelink, M., Brand, F.F. van den, Korkmaz, K.S., Berg, A.P. van den, Guichelaar, M.M.J., Soufidi, K., Levens, A.D., Hoek, B. van, Drenth, J.P.H., Dutch Autoimmune Hepatitis Working
Publikováno v:
Trials, 23(1):1012. BioMed Central Ltd.
Trials, 23(1):1012. BioMed Central
TRIALS, 23(1):1012. BMC
on behalf of the Dutch Autoimmune Hepatitis Working Group 2022, ' Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial) : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 1012 . https://doi.org/10.1186/s13063-022-06890-w
Trials
Trials, 23(1). BMC
Trials, 23, 1
Trials, 23(1). BioMed Central Ltd
Trials, 23
Trials, 23(1):1012. BioMed Central
TRIALS, 23(1):1012. BMC
on behalf of the Dutch Autoimmune Hepatitis Working Group 2022, ' Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial) : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 1012 . https://doi.org/10.1186/s13063-022-06890-w
Trials
Trials, 23(1). BMC
Trials, 23, 1
Trials, 23(1). BioMed Central Ltd
Trials, 23
Background Currently, the standard therapy for autoimmune hepatitis (AIH) consists of a combination of prednisolone and azathioprine. However, 15% of patients are intolerant to azathioprine which necessitates cessation of azathioprine or changes in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f268f0c5f0c5d471147b4cc9c9b0876
https://hdl.handle.net/1887/3564045
https://hdl.handle.net/1887/3564045
Autor:
Schaik, M. van, Arends, E.J., Soonawala, D., Ommen, E. van, Leeuw, K. de, Limper, M., Paassen, P. van, Huizinga, T.W.J., Toes, R.E.M., Kooten, C. van, Rotmans, J.I., Rabelink, T.J., Teng, Y.K.O.
Publikováno v:
Trials, 23
Trials, 23, 1
Trials, 23(1):939. BioMed Central Ltd
TRIALS, 23(1):939. BMC
Trials, 23(1). BMC
Trials, 23, 1
Trials, 23(1):939. BioMed Central Ltd
TRIALS, 23(1):939. BMC
Trials, 23(1). BMC
Background Belimumab, an anti-B-cell activating factor antibody, is approved for the treatment of auto-antibody positive systemic lupus erythematosus with a high degree of disease activity. Anti-CD20 B cell depletion with rituximab is used in refract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70084a3ecb1926a3b2b1879d2380755
http://hdl.handle.net/2066/285290
http://hdl.handle.net/2066/285290
Autor:
Philip Therkildsen, Annette de Thurah, Berit Dalsgaard Nielsen, Ib Tønder Hansen, Nikolaj Eldrup, Mette Nørgaard, Ellen-Margrethe Hauge
Publikováno v:
Therkildsen, P, de Thurah, A, Nielsen, B D, Hansen, I T, Eldrup, N, Nørgaard, M & Hauge, E-M 2022, ' Increased risk of thoracic aortic complications among patients with giant cell arteritis : a nationwide, population-based cohort study ', Rheumatology (Oxford, England), vol. 61, no. 7, pp. 2931–2941 . https://doi.org/10.1093/rheumatology/keab871
Objective To assess the risk of aortic aneurysms (AA), aortic dissections (AD) and peripheral arterial disease (PAD) among patients with GCA. Methods In this nationwide, population-based cohort study using Danish national health registries, we identi
Autor:
Hector Pardo-Hernandez, Mónica Novoa, A. Shahbaz, Ingrid Arevalo-Rodriguez, Lucia Giraldo, Sandra Beltran, Eulalia Baselga
Publikováno v:
Cochrane Database of Systematic Reviews
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Cochrane Library
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Cochrane Library
BACKGROUND: Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These benign vascular tumours are usually uncomplicated and tend to regress spontaneously. Howev
Autor:
Joanna Gale, C.L. Ferguson, J. Martin Russell, Prabir Chakraborti, Carys Thomas, Mohan Hingorani, Joe M. O'Sullivan, Anjali Zarkar, Clare Gilson, Zafar Malik, John Wagstaff, Jo Bowen, Fiona McKinna, Angus Robinson, Claire Amos, Simon Chowdhury, Alison Birtle, Fawzi Adab, Peter Hoskin, San Aung, Robin Millman, Chris Parker, Neil McPhail, Alastair W. S. Ritchie, Robert Jones, Jason F. Lester, Noel W. Clarke, Susannah Brock, Gerhardt Attard, Andrew Protheroe, James D. Wylie, Omi Parikh, Johann S. de Bono, Nicholas D. James, Julian Money-Kyrle, Malcolm David Mason, William Cross, Emma Gray, David Matheson, Dominik Berthold, Silke Gillessen, Melissa R. Spears, David P. Dearnaley, Narayanan Srihari, Matthew R. Sydes, Mahesh K.B. Parmar, Chris Brawley
Publikováno v:
STAMPEDE investigators 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
STAMPEDE Investigators & Gillessen, S 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', The New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
The New England journal of medicine, vol. 377, no. 4, pp. 338-351
STAMPEDE Investigators & Gillessen, S 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', The New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
The New England journal of medicine, vol. 377, no. 4, pp. 338-351
BACKGROUND: Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae654176b4379045bb5aaa6609f18434
https://pure.qub.ac.uk/en/publications/bca063cc-7a5e-46eb-95d8-7e27f2cf88b6
https://pure.qub.ac.uk/en/publications/bca063cc-7a5e-46eb-95d8-7e27f2cf88b6
Autor:
Jan W. Koper, Nynke Teeninga, Marie C Kersten, Joana E. Kist-van Holthe, Hans G Krabbe, Eric Boersma, Albert J. van der Heijden, Erica L T van den Akker, Jeroen Nauta, Nine V A M Knoers
Publikováno v:
Kidney International, 85(6), 1444-1453. ELSEVIER SCIENCE INC
Pediatric Nephrology, 28(8), 1596-1596. Springer
Teeninga, N, van Holthe, J E, van den Akker, E L T, Kersten, M C, Boersma, E, Krabbe, H G, Knoers, N V A M, van der Heijden, A J, Koper, J W & Nauta, J 2014, ' Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome ', Kidney International, vol. 85, no. 6, pp. 1444-1453 . https://doi.org/10.1038/ki.2013.531
Kidney International, 85(6), 1444-1453. Nature Publishing Group
Pediatric Nephrology, 28(8), 1596-1596. Springer
Teeninga, N, van Holthe, J E, van den Akker, E L T, Kersten, M C, Boersma, E, Krabbe, H G, Knoers, N V A M, van der Heijden, A J, Koper, J W & Nauta, J 2014, ' Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome ', Kidney International, vol. 85, no. 6, pp. 1444-1453 . https://doi.org/10.1038/ki.2013.531
Kidney International, 85(6), 1444-1453. Nature Publishing Group
Following initial glucocorticoid treatment, the clinical course in children with nephrotic syndrome is highly variable. Intrinsic sensitivity to glucocorticoids might be a determinant of this variability. Functional polymorphisms of the glucocorticoi
Publikováno v:
Transplant Infectious Disease. 4(1):17-24
Background. In this retrospective single center study we have evaluated the relation between the immunosuppressive regimen and the incidence and characteristics of cytomegalovirus (CMV) infection in the setting without CMV prophylaxis from 1989 throu
Bilateral Multifocal Retinal Pigment Epithelium Detachments Associated with Systemic Corticosteroids
Autor:
Efstratios Mendrinos, Constantin J. Pournaras, Nikolaos Mavrakanas, Nathalie P. Dang-Burgener
Publikováno v:
European Journal of Ophthalmology, Vol. 18, No 4 (2008) pp. 649-651
PURPOSE: To report an unusual case of central serous chorioretinopathy (CSC), presenting as bilateral and multifocal isolated serous retinal pigment epithelium detachments (RPEDs) following corticosteroid treatment. METHODS: An otherwise healthy 39-y
Autor:
Wim H. A. Dokter, Bruno Guigas, Jacob de Vlieg, Wynand Alkema, Margot M. Linssen, Wilco W. M. Fleuren, D. Margriet Ouwens, Erik J M Toonen, Gerard C.M. van der Zon
Publikováno v:
Archives of Physiology and Biochemistry, 119, 52-64
Archives of Physiology and Biochemistry, 119(2), 52-64
Archives of Physiology and Biochemistry
Archives of Physiology and Biochemistry, 119(2), 52-64. Swets & Zeitlinger
Archives of Physiology and Biochemistry, 119, 2, pp. 52-64
Archives of Physiology and Biochemistry, 119(2), 52-64
Archives of Physiology and Biochemistry
Archives of Physiology and Biochemistry, 119(2), 52-64. Swets & Zeitlinger
Archives of Physiology and Biochemistry, 119, 2, pp. 52-64
Contains fulltext : 117166.pdf (Publisher’s version ) (Open Access) Synthetic glucocorticoids are potent anti-inflammatory drugs but show dose-dependent metabolic side effects such as the development of insulin resistance and obesity. The precise m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9011fbcb761062c5e728fe89359da48a
http://hdl.handle.net/2066/117166
http://hdl.handle.net/2066/117166